AbReptor™
AbReptor is a first and best-in-class, transformative and modular bi-specific and multi-specific antibody platform designed to degrade membrane-bound and extracellular proteins.
AbReptor works by co-engaging a surface-receptor or extracellular protein of interest together with another proprietary receptor target.
AbReptor works by co-engaging a surface-receptor or extracellular protein of interest together with another proprietary receptor target.
- TPD Platform – Targeted Protein Degradation
- Antibody-based platform combines direct tumor targeting with immuno-oncology in single molecule
- Platform to generate multispecific antibodies to degrade kinase and non-kinase receptors
- Potentially applicable to all oncogenic receptor tyrosine kinases and immune checkpoint inhibitors
- Ability to address key unmet needs of drug resistance and tumor recurrence
Pinetree Therapeutics
West Cambridge Scientific Park
767C Concord Ave
Cambridge MA 02138
Website designed by Creative Eye Design
West Cambridge Scientific Park
767C Concord Ave
Cambridge MA 02138
Website designed by Creative Eye Design